|Bid||2.70 x 200|
|Ask||39.80 x 100|
|Day's Range||3.03 - 3.14|
|52 Week Range||2.82 - 6.30|
|PE Ratio (TTM)||-1.42|
|Earnings Date||Jul 27, 2017 - Jul 31, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||4.50|
Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Sunesis Pharmaceuticals, Inc. concerning possible violations of federal securities laws.
In light of a decision to pull its application for approval of vosaroxin in the European Union, Sunesis Pharmaceuticals Inc. has designated its BTK inhibitor program targeting chronic lymphocytic leukemia ...
NEW YORK, May 15, 2017 /PRNewswire/ -- Anadarko Petroleum Corporation (APC) Lifshitz & Miller announces investigation on behalf of APC investors concerning whether APC failed to maintain adequate safety ...